Volpara Health Technologies logo

VHT - Volpara Health Technologies Share Price

A$1.25 0.0  0.0%

Last Trade - 10/05/21

Small Cap
Market Cap £176.0m
Enterprise Value £145.6m
Revenue £7.92m
Position in Universe 507th / 1907
Unlock VHT Revenue
Relative Strength (%)
1m -14.9%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -27.1%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
2.41 2.61 2.05 2.81 5.00 12.6 21.6 27.5 +39.2%
Balance Sheet
FINANCIAL BRIEF: : For the six months ended 30 September 2020, VolparaHealth Technologies Ltd revenues increased 38% to NZ$9.5M.Net loss increased 11% to NZ$8.9M. Revenues reflect anincrease in demand for the Company's products and servicesdue to favorable market conditions. Higher net lossreflects Research & Development Expense increase of 58% toNZ$7.2M (expense), Foreign exchange gains increase fromNZ$468K (income) to NZ$261K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


VHT Revenue Unlock VHT Revenue

Net Income

VHT Net Income Unlock VHT Revenue

Normalised EPS

VHT Normalised EPS Unlock VHT Revenue

PE Ratio Range

VHT PE Ratio Range Unlock VHT Revenue

Dividend Yield Range

VHT Dividend Yield Range Unlock VHT Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
VHT EPS Forecasts Unlock VHT Revenue
Profile Summary

Volpara Health Technologies Limited is a New Zealand-based research, development, and manufacturing company that provides breast imaging analytics and analysis products. The Company is engaged in developing digital health solutions to enable personalized breast cancer screening based on objective measurements of breast density, compression, and radiation dose. Its geographic segments include North America, Europe, the Middle East and Africa (EMEA), Asia-Pacific (APAC), and Corporate. The Company's offerings include VolparaEnterprise, which enables breast imaging providers to perform control checks; VolparaDensity, which provides objective assessment of a woman's breast density; VolparaRisk is a software that features a patient questionnaire; VolparaLive provides technologists with real-time decision support at the point of care to assess image quality, and Aspen Brest, which is a workflow software that optimizes operations and administration for breast cancer screening programs.

Last Annual March 31st, 2020
Last Interim September 30th, 2020
Incorporated February 24, 2009
Public Since April 27, 2016
No. of Shareholders: 14,455
No. of Employees: 174
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index S&P/ASX All Ordinaries ,
Exchange Australian Stock Exchange - SEATS
Shares in Issue 250,819,000
Free Float (0.0%)
Eligible for
VHT Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for VHT
Upcoming Events for VHT
Thursday 19th August, 2021 Estimate
Volpara Health Technologies Ltd Annual Shareholders Meeting
Frequently Asked Questions for Volpara Health Technologies
What is the Volpara Health Technologies share price?

As of 10/05/21, shares in Volpara Health Technologies are trading at A$1.25, giving the company a market capitalisation of £176.0m. This share price information is delayed by 15 minutes.

How has the Volpara Health Technologies share price performed this year?

Shares in Volpara Health Technologies are currently trading at A$1.25 and the price has moved by -4.94% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Volpara Health Technologies price has moved by -28.78% over the past year.

What are the analyst and broker recommendations for Volpara Health Technologies?

Of the analysts with advisory recommendations for Volpara Health Technologies, there are there are currently 1 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Volpara Health Technologies is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Volpara Health Technologies next release its financial results?

Volpara Health Technologies is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-09-30
What is the Volpara Health Technologies dividend yield?

Volpara Health Technologies does not currently pay a dividend.

Does Volpara Health Technologies pay a dividend?

Volpara Health Technologies does not currently pay a dividend.

When does Volpara Health Technologies next pay dividends?

Volpara Health Technologies does not currently pay a dividend.

How do I buy Volpara Health Technologies shares?

To buy shares in Volpara Health Technologies you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Volpara Health Technologies?

Shares in Volpara Health Technologies are currently trading at A$1.25, giving the company a market capitalisation of £176.0m.

Where are Volpara Health Technologies shares listed? Where are Volpara Health Technologies shares listed?

Here are the trading details for Volpara Health Technologies:

Country of listing: Australia
Exchange: ASX
Ticker Symbol: VHT
What kind of share is Volpara Health Technologies?

Based on an overall assessment of its quality, value and momentum, Volpara Health Technologies is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Volpara Health Technologies share price forecast 2021?

Shares in Volpara Health Technologies are currently priced at A$1.25. At that level they are trading at 44.59% discount to the analyst consensus target price of 0.00.

Analysts covering Volpara Health Technologies currently have a consensus Earnings Per Share (EPS) forecast of -0.0601106832 for the next financial year.

How can I tell whether the Volpara Health Technologies share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Volpara Health Technologies. Over the past six months, the relative strength of its shares against the market has been -15.75%. At the current price of A$1.25, shares in Volpara Health Technologies are trading at -9.37% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Volpara Health Technologies PE Ratio?

We were not able to find PE ratio data for Volpara Health Technologies.

Who are the key directors of Volpara Health Technologies?

Volpara Health Technologies's management team is headed by:

Roger Allen - NED
Ralph Highnam - CEO
John Pavlidis - NID
Julian Marshall - CMO
David Murray - CTO
David Mezzoprete - VPR
Ian Hendra - OTH
Penelope Gibson - OTH
Anton Zerle - VPR
David Lee - VPR
Craig Hadfield - CFO
Paul Reid - CHM
Monica Saini - DRC
Karin Lindgren - NID
Who are the major shareholders of Volpara Health Technologies?

Here are the top five shareholders of Volpara Health Technologies based on the size of their shareholding:

Harbour Asset Management Limited Investment Advisor
Percentage owned: 7.84% (19.7m shares)
Allen (Roger) Individual Investor
Percentage owned: 7.36% (18.5m shares)
Highnam (Ralph) Individual Investor
Percentage owned: 6.46% (16.2m shares)
Brady (John Michael) Individual Investor
Percentage owned: 2.84% (7.12m shares)
Brady (Michael) Individual Investor
Percentage owned: 2.64% (6.62m shares)
Similar to VHT
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.